TRACON Pharmaceuticals Q3 EPS $(0.17) Beats $(0.2) Estimate

TRACON Pharmaceuticals (NASDAQ:TCON) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.2) by 15 percent. This is a 43.33 percent increase over losses of $(0.3) per share from

Benzinga · 11/05/2019 21:26

TRACON Pharmaceuticals (NASDAQ:TCON) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.2) by 15 percent. This is a 43.33 percent increase over losses of $(0.3) per share from the same period last year.